Botanical and Plant Derived Drugs Market
- 2026 年市場規模
- USD 52.6 Bn
- 2033 年預估規模
- USD 80.7 Bn
- 年複合成長率 CAGR
- 6.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Botanical and Plant Derived Drugs Market, By Source (Plant, Algae, Macroscopic fungi, and Others), By Dosage Form (Pills, Tablets, Capsules, and Injection), By Therapeutic Application (Central Nervous System, Cardiovascular Diseases, Infectious Diseases, and Respiratory Diseases), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Botanical and plant derived drugs contain active ingredients derived from plants. The botanical drug is a mixture of plant materials that include whole plant, part of plants, fungi or algae. Plants have been used as a source of medicine since past, owing to side effects caused due to consumption of synthetic drugs the botanical and plant derived drugs are preferred over the synthetic drugs.
Furthermore, the botanical drugs are clinically evaluated for safety and efficacy just as conventional drugs. Besides, this legalization of medical cannabis is also expected to foster growth of the botanical and plant derived drugs market.
Market Dynamics
The global botanical and plant derived drugs market is projected to witness significant growth over the forecast period, owing to legalization of medical cannabis. Medical cannabis was legalized in the Czech Republic, in 2013, Argentina and Chile in 2015, and in 2016, marijuana legalization in America reached a tipping point, as the medical marijuana became legal in some of the states.
Hence, many manufacturers are focused on research and development on medical cannabis to launch new drugs. For instance, one of the drug by GW Pharmaceuticals, Epidiolex consists of cannabidivarin (CBDV) is in developmental process, which will be used in clinical trials for treatment resistant epilepsy, supported by NSW and Queensland government in 2016.
Furthermore, increasing number of chronic disease supports the growth of botanical and plant derived drugs, as lung cancer accounts for the leading cause of death in the Eastern, Southern and Southeastern Asia. The region holds for 56% of the world’s population and contributes to 44% of the total cancer cases worldwide according to the statistics mentioned in the Cancer Atlas.
Key features of the study
• This report provides in-depth analysis of the Botanical and plant derived drugs market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period: 2026 – 2033, considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global botanical and plant derived drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key companies covered as a part of this study include Bayer Healthcare, GlaxoSmithKline, Pfizer, Inc. Sanofi, Actelion Pharmaceuticals, Aimil Pharmaceuticals, Allergan, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Concordia Pharmaceuticals, GW Pharmaceuticals, LEO Pharma, MEDICAGO, and Merck.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, market expansion, and marketing tactics.
• The global botanical and plant derived drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for botanical and plant derived drugs market, research and consulting firms, new entrants, and financial analysts.
Market Segmentation
• By Source (Revenue, USD Bn, 2021-2033)
o Plant
o Algae
o Macroscopic fungi
o Others
• By Dosage Form (Revenue, USD Bn, 2021-2033)
o Pills
o Tablets
o Capsules
o Injection
• By Therapeutic Application (Revenue, USD Bn, 2021-2033)
o Central Nervous System
o Cardiovascular Diseases
o Infectious Diseases
o Respiratory Diseases
• By Region
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
North Africa
South Africa
Central Africa
• Key Players
o Bayer Healthcare
o GlaxoSmithKline
o Pfizer, Inc.
o Sanofi
o Actelion Pharmaceuticals
o Aimil Pharmaceuticals
o Allergan
o AstraZeneca
o Boehringer Ingelheim
o GW Pharmaceuticals
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Global Botanical and Plant Derived Drugs Market, By Source
Global Botanical and Plant Derived Drugs Market, By Dosage Form
Global Botanical and Plant Derived Drugs Market, By Therapeutic Application
Global Botanical and Plant Derived Drugs Market, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Recent product launches
o Regulatory Scenario
o Awareness initiatives
o PEST Analysis
o PORTER’s Analysis
o Epidemiology
4. Global Botanical and Plant Derived Drugs Market, By Source, 2021 – 2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Plant
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Algae
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Macroscopic fungi
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
5. Global Botanical and Plant Derived Drugs Market, By Dosage Form, 2021 – 2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Pills
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Tablets
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Capsules
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Injection
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
6. Global Botanical and Plant Derived Drugs Market, By Therapeutic Application, 2021 – 2033, (US$ Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Central Nervous System
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Cardiovascular Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
o Respiratory Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (US$ Billion)
7. Global Botanical and Plant Derived Drugs Market, By Regions, 2021 – 2033, (US$ Billion)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2022 – 2033
Regional Trends
o North America
Market Size and Forecast, By Source, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Dosage Form, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Therapeutic Application, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Countries, 2021 – 2033, (US$ Billion)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Source, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Dosage Form, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Therapeutic Application, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Countries, 2021 – 2033, (US$ Billion)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Latin America
Market Size and Forecast, By Source, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Dosage Form, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Therapeutic Application, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Countries, 2021 – 2033, (US$ Billion)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Asia Pacific
Market Size and Forecast, By Source, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Dosage Form, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Therapeutic Application, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Countries, 2021 – 2033, (US$ Billion)
o China
o India
o Japan
o Australia
o ASEAN
o South Korea
o Rest of Asia Pacific
o Middle East
Market Size and Forecast, By Source, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Dosage Form, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Therapeutic Application, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Countries, 2021 – 2033, (US$ Billion)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Source, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Dosage Form, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Therapeutic Application, 2021 – 2033, (US$ Billion)
Market Size and Forecast, By Countries, 2021 – 2033, (US$ Billion)
o North Africa
o Central Africa
o South Africa
8. Competitive Landscape
o Company Profiles
Bayer Healthcare
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
GlaxoSmithKline
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Pfizer, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Sanofi
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Actelion Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Aimil Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Allergan
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
AstraZeneca
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Boehringer Ingelheim
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
GW Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們